| KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
0.35 |
Evidence |
|
| CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.35 |
Evidence |
|
| F13B |
F13B: Coagulation factor XIII B chain precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.35 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
OXTR |
OXTR: Oxytocin receptor |
0.35 |
Evidence |
|
| APOB |
APOB: Apolipoprotein B-100 precursor |
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
0.35 |
Evidence |
|
| CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
MYF5 |
MYF5: Myogenic factor 5 |
0.35 |
Evidence |
|
| LHB |
LHB: Lutropin subunit beta precursor |
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
0.35 |
Evidence |
|
| LHB |
LHB: Lutropin subunit beta precursor |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
0.35 |
Evidence |
|
| EDD1 |
EDD1, EDD, HYD, KIAA0896: E3 ubiquitin-protein ligase EDD1 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
0.35 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
0.35 |
Evidence |
|
| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.347 |
Evidence |
|
| CCND2 |
CCND2: G1/S-specific cyclin-D2 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
0.347 |
Evidence |
|
| INHBA |
INHBA: Inhibin beta A chain precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.347 |
Evidence |
|
| LOC653763 |
GCSH: Glycine cleavage system H protein, mitochondrial precursor |
KRTAP10-8 |
KRTAP10-8, KAP10.8, KAP18-8, KRTAP10.8, KRTAP18-8, KRTAP18.8: Keratin-associated |
0.347 |
Evidence |
|
| PRKACB |
IPI00376119 |
ABCA12 |
|
0.347 |
Evidence |
|
| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
ABCA12 |
|
0.347 |
Evidence |
|
| MGAM |
MGAM, MGA, MGAML: Maltase-glucoamylase, intestinal [Includes: Maltase |
PRKACB |
IPI00376119 |
0.347 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.347 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.347 |
Evidence |
|
| CTSZ |
CTSZ: Cathepsin Z precursor |
CST7 |
CST7: Cystatin-F precursor |
0.347 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.347 |
Evidence |
|
| CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.347 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.347 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.347 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.347 |
Evidence |
|